| Inferring tumour purity and stromal and immune cell admixture from expression data K Yoshihara, M Shahmoradgoli, E Martínez, R Vegesna, H Kim, ... Nature communications 4 (1), 2612, 2013 | 6813 | 2013 |
| Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas Cancer Genome Atlas Research Network New England Journal of Medicine 372 (26), 2481-2498, 2015 | 3006 | 2015 |
| Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin KA Hoadley, C Yau, DM Wolf, AD Cherniack, D Tamborero, S Ng, ... Cell 158 (4), 929-944, 2014 | 1570 | 2014 |
| Comprehensive pan-genomic characterization of adrenocortical carcinoma S Zheng, AD Cherniack, N Dewal, RA Moffitt, L Danilova, BA Murray, ... Cancer cell 29 (5), 723-736, 2016 | 666 | 2016 |
| A pan-cancer proteomic perspective on The Cancer Genome Atlas R Akbani, PKS Ng, HMJ Werner, M Shahmoradgoli, F Zhang, Z Ju, W Liu, ... Nature communications 5 (1), 3887, 2014 | 569 | 2014 |
| The landscape and therapeutic relevance of cancer-associated transcript fusions K Yoshihara, Q Wang, W Torres-Garcia, S Zheng, R Vegesna, H Kim, ... Oncogene 34 (37), 4845-4854, 2015 | 487 | 2015 |
| Clonal expansion and diversification of cancer-associated mutations in endometriosis and normal endometrium K Suda, H Nakaoka, K Yoshihara, T Ishiguro, R Tamura, Y Mori, ... Cell reports 24 (7), 1777-1789, 2018 | 369 | 2018 |
| Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013; 4: 2612 K Yoshihara, M Shahmoradgoli, E Martínez, R Vegesna, H Kim, ... | 356 | 2024 |
| Meta-analysis identifies five novel loci associated with endometriosis highlighting key genes involved in hormone metabolism Y Sapkota, V Steinthorsdottir, AP Morris, A Fassbender, N Rahmioglu, ... Nature communications 8 (1), 15539, 2017 | 309 | 2017 |
| TumorFusions: an integrative resource for cancer-associated transcript fusions X Hu, Q Wang, M Tang, F Barthel, S Amin, K Yoshihara, FM Lang, ... Nucleic acids research 46 (D1), D1144-D1149, 2018 | 212 | 2018 |
| Gene expression profiling of advanced‐stage serous ovarian cancers distinguishes novel subclasses and implicates ZEB2 in tumor progression and prognosis K Yoshihara, A Tajima, D Komata, T Yamamoto, S Kodama, H Fujiwara, ... Cancer science 100 (8), 1421-1428, 2009 | 195 | 2009 |
| High-risk ovarian cancer based on 126-gene expression signature is uniquely characterized by downregulation of antigen presentation pathway K Yoshihara, T Tsunoda, D Shigemizu, H Fujiwara, M Hatae, H Fujiwara, ... Clinical cancer research 18 (5), 1374-1385, 2012 | 180 | 2012 |
| Gene expression profile for predicting survival in advanced-stage serous ovarian cancer across two independent datasets K Yoshihara, A Tajima, T Yahata, S Kodama, H Fujiwara, M Suzuki, ... PloS one 5 (3), e9615, 2010 | 163 | 2010 |
| Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun 4: 2612 K Yoshihara, M Shahmoradgoli, E Martínez, R Vegesna, H Kim, ... DOI: https://doi. org/10.1038/ncomms3612, PMID 24113773, 2013 | 157 | 2013 |
| Serum leptin–adiponectin ratio and endometrial cancer risk in postmenopausal female subjects N Ashizawa, T Yahata, J Quan, S Adachi, K Yoshihara, K Tanaka Gynecologic oncology 119 (1), 65-69, 2010 | 147 | 2010 |
| In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epithelial ovarian cancer M Kodama, T Kodama, JY Newberg, H Katayama, M Kobayashi, ... Proceedings of the National Academy of Sciences 114 (35), E7301-E7310, 2017 | 117 | 2017 |
| Meta-analysis of genome-wide association scans for genetic susceptibility to endometriosis in Japanese population S Adachi, A Tajima, J Quan, K Haino, K Yoshihara, H Masuzaki, ... Journal of human genetics 55 (12), 816-821, 2010 | 113 | 2010 |
| The first Japanese nationwide multicenter study of BRCA mutation testing in ovarian cancer: CHARacterizing the cross-sectionaL approach to Ovarian cancer geneTic TEsting of … T Enomoto, D Aoki, K Hattori, M Jinushi, J Kigawa, N Takeshima, H Tsuda, ... International Journal of Gynecologic Cancer 29 (6), 2019 | 107 | 2019 |
| Whole-genome sequencing revealed novel prognostic biomarkers and promising targets for therapy of ovarian clear cell carcinoma H Itamochi, T Oishi, N Oumi, S Takeuchi, K Yoshihara, M Mikami, ... British journal of cancer 117 (5), 717-724, 2017 | 104 | 2017 |
| Identification of receptor tyrosine kinase, discoidin domain receptor 1 (DDR1), as a potential biomarker for serous ovarian cancer J Quan, T Yahata, S Adachi, K Yoshihara, K Tanaka International journal of molecular sciences 12 (2), 971-982, 2011 | 96 | 2011 |
